Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
MSI Morgan names expanded global wealth management offerings top strategic priority for 2024 Comm West CWBC Stock Valuation Gap Analysis Comm West posts 2 EPS beat topping analyst consensus estimates StealthGas GASS Stock Whats Next Slow Grind 20260420 Tron TRON Year in Review Tron withholds core financials amid Web3 expansion Arbor Realty ABR Stock Adds to Position Under Pressure 20260423 Mondelez International MDLZ Investment Thesis Q1 2026 Profit Surprises What is affecting loanDepot LDI stock valuation Q4 2025 Earnings Underperform MRX Marex delivers 94 percent Q4 2025 EPS beat yet shares drop 161 percent on muted investor reaction Tesla Inc TSLA Gains Broader Retail Investor Visibility Following X Platform Smart Cashtags Launch Warren Buffetts Tiny Purchase Hint May Be Revealed in Latest Berkshire Filing Childrens PLCE Q1 2026 Results Fall Short EPS 186 Revenue NA Amentum AMTM Stock Up 128 Key Resistance at 2443 20260518 What Sunshine Biopharma SBFMs 3776 Decline Means for Investors 20260515 Why Integra ITRG Just Surged 289 Key Levels Ahead 20260520 GraniteShares Announces Weekly Distributions for YieldBOOST ETFs Shell PLC SHEL Posts Q1 2026 Earnings Beat Heres What Drove It Global Oil Supply at Risk Over 160 Tankers Stranded as Iran Tightens Grip on Strait of Hormuz MNST Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability VTEX Q1 2026 Earnings EPS Misses Estimates Stock Declines NACCO Industries NC Q1 2026 Earnings Strong EPS Results Lift Shares Amid Sparse Disclosure MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Stock Still Rises CSTE Q1 2026 Earnings EPS Surpasses Estimates Despite Net Loss Black Spade Acquisition III Co BIII Holds Steady at 992 as SPAC Awaits Business Combination Catalyst Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback Crexendo Inc CXDO Holds Steady Near Resistance as Volume Patterns Signal Cautious Optimism Cartesian Therapeutics RNAC Slumps 77 as Selling Pressure Intensifies